UroXatral launch
Executive Summary
Sanofi expects to launch UroXatral (once-daily alfuzosin) for benign prostatic hyperplasia treatment in 2003; Sanofi and SkyePharma received an "approvable" letter from FDA in October 2001 (1"The Pink Sheet" Oct. 15, 2001, In Brief)...